Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

842 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using the 6-minute walk test to predict disability-free survival after major surgery.
Shulman MA, Cuthbertson BH, Wijeysundera DN, Pearse RM, Thompson B, Torres E, Ambosta A, Wallace S, Farrington C, Myles PS; Measurement of Exercise Tolerance for Surgery Study Investigators. Shulman MA, et al. Br J Anaesth. 2019 Jan;122(1):111-119. doi: 10.1016/j.bja.2018.08.016. Epub 2018 Oct 9. Br J Anaesth. 2019. PMID: 30579389 Free article.
Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery.
Wijeysundera DN, Pearse RM, Shulman MA, Abbott TE, Torres E, Croal BL, Granton JT, Thorpe KE, Grocott MP, Farrington C, Myles PS, Cuthbertson BH; METS Study Investigators. Wijeysundera DN, et al. BMJ Open. 2016 Mar 11;6(3):e010359. doi: 10.1136/bmjopen-2015-010359. BMJ Open. 2016. PMID: 26969643 Free PMC article.
Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study.
Wijeysundera DN, Beattie WS, Hillis GS, Abbott TEF, Shulman MA, Ackland GL, Mazer CD, Myles PS, Pearse RM, Cuthbertson BH; Measurement of Exercise Tolerance before Surgery Study Investigators; Myles PS, Shulman MA, Wallace S, Farrington C, Thompson B, Ellis M, Borg B, Kerridge RK, Douglas J, Brannan J, Pretto J, Godsall MG, Beauchamp N, Allen S, Kennedy A, Wright E, Malherbe J, Ismail H, Riedel B, Melville A, Sivakumar H, Murmane A, Kenchington K, Kirabiyik Y, Gurunathan U, Stonell C, Brunello K, Steele K, Tronstad O, Masel P, Dent A, Smith E, Bodger A, Abolfathi M, Sivalingam P, Hall A, Painter TW, Macklin S, Elliott A, Carrera AM, Terblanche NCS, Pitt S, Samuels J, Wilde C, Leslie K, MacCormick A, Bramley D, Southcott AM, Grant J, Taylor H, Bates S, Towns M, Tippett A, Marshall F, Mazer CD, Kunasingam J, Yagnik A, Crescini C, Yagnik S, McCartney CJL, Choi S, Somascanthan P, Flores K, Wijeysundera DN, Beattie WS, Karkouti K, Clarke HA, Jerath A, McCluskey SA, Wasowicz M, Granton JT, Day L, Pazmino-Canizares J, Oh P, Belliard R, Lee L, Dobson K, Chan V, Brull R, Ami N, Stanbrook M, Hagen K, Campbell D, Short T, Van Der Westhuizen J, Higgie K, Lindsay H, Jang R, Wong C, Mcal… See abstract for full author list ➔ Wijeysundera DN, et al. Among authors: day l. Br J Anaesth. 2020 Mar;124(3):261-270. doi: 10.1016/j.bja.2019.11.025. Epub 2019 Dec 19. Br J Anaesth. 2020. PMID: 31864719 Free article.
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women.
Renz S, Chinnery F, Stuart B, Day L, Muller I, Soulsby I, Nuttall J, Thomas K, Thomas KS, Sach T, Stanton L, Ridd MJ, Francis N, Little P, Eminton Z, Griffiths G, Layton AM, Santer M. Renz S, et al. Among authors: day l. BMJ Open. 2021 Aug 26;11(8):e053876. doi: 10.1136/bmjopen-2021-053876. BMJ Open. 2021. PMID: 34446504 Free PMC article.
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial.
Davies A, Barrans S, Burton C, Mercer K, Caddy J, Chinnery F, Day L, Fernando D, Ardeshna K, Collins G, Radford J, Rule S, McMillan A, Johnson P, Griffiths G. Davies A, et al. Among authors: day l. F1000Res. 2020 Aug 7;9:941. doi: 10.12688/f1000research.22318.1. eCollection 2020. F1000Res. 2020. PMID: 33093947 Free PMC article.
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
Crabb SJ, Danson S, Catto JWF, Hussain S, Chan D, Dunkley D, Downs N, Marwood E, Day L, Saunders G, Light M, Whitehead A, Ellis D, Sarwar N, Enting D, Birtle A, Johnson B, Huddart R, Griffiths G. Crabb SJ, et al. Among authors: day l. Clin Cancer Res. 2021 Apr 1;27(7):1882-1892. doi: 10.1158/1078-0432.CCR-20-3946. Epub 2021 Jan 20. Clin Cancer Res. 2021. PMID: 33472913 Free PMC article. Clinical Trial.
842 results